Home > EMCDDA–Europol joint report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl).

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol joint report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl). Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl)) - Published Version
1MB

In September 2016, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, commonly known as acryloylfentanyl, through a joint assessment based upon the following criteria:

1. the amount of the material seized;

2. evidence of organised crime involvement;

3. evidence of international trafficking;

4. analogy with better-studied compounds;

5. evidence of the potential for further (rapid) spread; and,

6. evidence of cases of serious intoxication or fatalities.

The EMCDDA and Europol agreed that the information collected on acryloylfentanyl satisfied criteria 4 and 6. The two agencies therefore concluded that sufficient information had been accumulated to merit the production of a Joint Report on acryloylfentanyl as stipulated by Article 5.1 of the Council Decision.

Item Type
Report
Publication Type
International, Report
Drug Type
New psychoactive substance
Intervention Type
Harm reduction
Date
February 2017
Pages
24 p.
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page